Vaccine-induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains (original) (raw)

The Cellular Immune Response to Mycobacterium tuberculosis Infection in the Guinea Pig

Marcela Henao Tamayo

The Journal of Immunology, 2007

View PDFchevron_right

Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection

Frank Verreck

Cell Reports Medicine, 2021

View PDFchevron_right

BCG vaccination is associated with decreased severity of tuberculosis in Pakistan

MUHAMMAD HARIS

International Journal of Mycobacteriology, 2012

View PDFchevron_right

Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis : Scope in diagnosis, vaccine design and therapy

Amir Khan

Critical Reviews in Microbiology, 2011

View PDFchevron_right

Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein

Mark Alderson

The Journal of Immunology, 2004

View PDFchevron_right

Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity

Neio Boéchat

The Journal of Immunology, 2009

View PDFchevron_right

Mycobacteria-Specific T Cells Are Generated in the Lung During Mucosal BCG Immunization or Infection With Mycobacterium tuberculosis

Martin Rottenberg

Frontiers in Immunology, 2020

View PDFchevron_right

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development

Tom h.m. Ottenhoff

Frontiers in Immunology, 2017

View PDFchevron_right

Mycobacterium africanumElicits an Attenuated T Cell Response to Early Secreted Antigenic Target, 6 kDa, in Patients with Tuberculosis and Their Household Contacts

Simon Donkor

The Journal of Infectious Diseases, 2006

View PDFchevron_right

A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis

Marcela Henao Tamayo

Nature Medicine, 2011

View PDFchevron_right

BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers

Jai Mullerpattan

Clinical Infectious Diseases, 2016

View PDFchevron_right

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells

Sebastian Gelderbloem

European Journal of Immunology, 2009

View PDFchevron_right

BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells

andre cruz

Vaccine, 2015

View PDFchevron_right

Mucosal immunity and HIV/AIDS vaccines

Marc GIRARD

Vaccine, 2008

View PDFchevron_right

Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases

Huan Nguyen

Emerging Infectious Diseases, 2000

View PDFchevron_right

Challenging Mycobacterium tuberculosis dormancy mechanisms and their immunodiagnostic potential

Henrique Couto Teixeira

The Brazilian Journal of Infectious Diseases, 2015

View PDFchevron_right

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants

Michele Tameris

Research Square (Research Square), 2022

View PDFchevron_right

Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model

José Sifuentes-osornio

Immunology, 2009

View PDFchevron_right

Health care workers humoral immune response against GLcB, MPT51 and HSPX from Mycobacterium tuberculosis

Andre Kipnis

Brazilian Journal of Infectious Diseases, 2009

View PDFchevron_right

Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis

Umesh Gupta

The Indian Journal of Medical Research, 2011

View PDFchevron_right

The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1immune response in mice

Carla Palma

Cellular Microbiology, 2007

View PDFchevron_right

Towards a New Challenge in TB Control: Development of Antibody-Based Protection

Maria Elena

intechopen.com

View PDFchevron_right

Tuberculosis and multi-drug resistant tuberculosis: immunologic mechanisms and tools for controlling the disease

Margareth Dalcolmo

RECIIS, 2008

View PDFchevron_right

Field test of a novel detection device for Mycobacterium tuberculosis antigen in cough

Beyene Wondafrash

BMC Infectious Diseases, 2010

View PDFchevron_right

Therapeutic vaccines

James Gulley

Human Vaccines & Immunotherapeutics, 2013

View PDFchevron_right